DNA Sequencing: Innovative Tool to Improve Understanding of Chronic Diseases With Limitless Opportunities

18 Jul
2019

 
6585 Views
 

DNA sequencing is a norm now. It has become as casual as taking a blood test. However, scientists are not done looking for new ways to put the technology to work. The last two decades have seen a revolution in DNA sequencing with boosted speed and efficiency along with a massive reduction in cost. Thanks to the increase in genome mapping programs and adoption of personalized medicine trends, the demand for DNA sequencing has skyrocketed. According to Allied Market Research, the global DNA sequencing market is projected to reach $25.47 billion by 2025, registering a CAGR of 19.0% from 2018 to 2025.

A genome is regarded as a body’s instruction manual, which is made of DNA and there is a copy in almost every cell. DNA sequencing gathered attention when researchers discovered that it can be used to understand how cancer cells work. Through DNA sequencing, clinicians can understand how cancer cells evolve and what treatments would be most effective. Additionally, if coupled with machine learning and artificial intelligence (AI), genomics could unlock new doors in healthcare and even determine a healthy person’s future risks of developing any chronic disease.

Cervical cancer is responsible for more than 7% of the cancer deaths in women across the world, but scientists still know very little about how mutation form in the tumor, which limits the potential to develop an effective drug against it. However, DNA sequencing could be the key to treat cervical cancer. Scientists compared the genomes of cervical tumors and healthy tissue taken from the same patient and discovered 13 mutations linked to cervical cancer. Out of them, eight were not associated with the disease and two were not known linked to cancer at all. According to researchers, it was the most significant finding as one of those genes were previously identified to be linked with breast cancer. This concludes that cervical cancer patients could be treated with existing therapies for breast cancer. Such advancements in healthcare have offered a new way to find treatments for cancer patients.

With the advent of DNA sequencing, the humongous amount of genetic data is piling up. However, not much of it gets interpreted. To solve this, HashedIn, a leading software as a solution (SaaS) company and Basepair have announced collaboration to develop a SaaS solution to deal with DNA sequencing data for personalized and predictive healthcare. HashedIn uses ANT design that helps scientists and clinicians from Harvard Medical School, University of California San Diego, and New York University to use Basepair to discover more about chronic diseases such as AIDS and cancer.

Basepair has developed a SaaS solution to analyze, manage, and interpret DNA sequencing data. Moreover, Basepair and HashedIn have offered ANT design to aid healthcare professionals to focus on scalable data analytics solutions. This would offer them a platform to expedite analysis workflows without investing money in computing resources and skilled personnel. As DNA sequencing has the potential to revolutionize medicine, agriculture, and research, leading institutes use Basepair to analyze huge DNA sequencing data and discover patterns to treat critical illness. This new SaaS solution offers users unprecedented visibility into their data. DNA sequencing is the beginning to yield insights for several diseases and more data would flood in over the next several years. Such collaboration to develop novel platforms could be regarded as the beginning of the bright future in healthcare to find answers for treating cancer and other critical illnesses.

 

 
Alex Hillsberg

Alex Hillsberg

Chief editor of review team at FinancesOnline

Chief editor of review team at FinancesOnline Alex Hillsberg is an expert in the area of B2B and SaaS related products. He has worked for several B2B startups in the past and gathered a lot of first hand knowledge about the industry during that time.

 
PREVIOUS POST
 

Developments in Biomarkers Market Answer Diagnosis Concerns

NEXT POST
 

Brain Health Supplements a Hack for Boosting Brain Functions

 

Related Post

Follow us on Social Media
 

Twitter Post

Allied Market Research
@marketresearcht

Follow

Global Smart Shoes Market to Reach $223.4 Million by 2026 at 9.1% CAGR: AMR Download Sample Copy Of Report@… https://t.co/Il3iv6b65y

0      0

Allied Market Research
@marketresearcht

Follow

VFX software market is escalating at a CAGR of 12.7% from 2019 to 2026, Says AMR Get Sample PDF:… https://t.co/oZynH0YrFo

0      0

Allied Market Research
@marketresearcht

Follow

Global Augmented and Virtual Reality Market to Reach $571.42 Billion by 2025 at 63.3% CAGR: Allied Market Research… https://t.co/0Y8EVIRYV2

1      1

Allied Market Research
@marketresearcht

Follow

Bug tracking software Market to Reach $601.64 Million by 2026 at 13.6% CAGR, Says Allied Market Research… https://t.co/u1Www84vsT

0      0

Allied Market Research
@marketresearcht

Follow

#Disposable #Protective #Clothing Market to Reach $4.68 Billion by 2026 Read More @ https://t.co/8GfZ6wzUo0 https://t.co/qoI0dSFOgZ

0      0